Emerging blood–brain-barrier-crossing nanotechnology for brain cancer theranostics
Новые нанотехнологии, преодолевающие гематоэнцефалический барьер, для тераностики рака мозга
2019-01-01
SCID: 54.1/p2y84e28
Discuss with AI
BBB-crossing nanotechnologyblood-brain barrierbrain cancer theranosticsglioblastomamultifunctional nanoplatforms
Figures from the paper
Abstract (AI)
Brain cancer, especially the most common type of glioblastoma, is highly invasive and known as one of the most devastating and deadly neoplasms. Despite surgical and medical advances, the prognosis for most brain cancer patients remains dismal and the median survival rarely exceeds 16 months. Drug delivery to the brain is significantly hindered by the existence of the blood-brain barrier (BBB), which serves as a protective semi-permeable membrane for the central nervous system. Recent breakthroughs in nanotechnology have yielded multifunctional theranostic nanoplatforms with the ability to cross or bypass the BBB, enabling accurate diagnosis and effective treatment of brain tumours. Herein, we make our efforts to present a comprehensive review on the latest remarkable advances in BBB-crossing nanotechnology, with an emphasis on the judicious design of multifunctional nanoplatforms for effective BBB penetration, efficient tumour accumulation, precise tumour imaging, and significant tumour inhibition of brain cancer. The detailed elucidation of BBB-crossing nanotechnology in this review is anticipated to attract broad interest from researchers in diverse fields to participate in the establishment of powerful BBB-crossing nanoplatforms for highly efficient brain cancer theranostics.
Key Findings
1
Effective BBB-crossing platforms are designed to improve barrier penetration, tumor accumulation, imaging precision, and therapeutic tumor inhibition.
2
Glioblastoma remains highly invasive and lethal, with median patient survival rarely exceeding 16 months despite advances in surgery and medical treatment.
3
Recent nanotechnology advances have produced multifunctional theranostic nanoplatforms capable of crossing or bypassing the BBB.
4
The blood–brain barrier substantially limits drug delivery to brain tumors while protecting the central nervous system.
5
The review highlights multifunctional nanoplatform design as a promising strategy for integrated diagnosis and treatment of brain cancer.
Research Object
blood–brain-barrier-crossing multifunctional theranostic nanoplatforms for brain cancer
Research Subject
their design and performance in BBB penetration, brain-tumour accumulation, precise imaging, and tumour inhibition
Publication Details
Publication Date
2019-01-01
Journal
Publisher
ISSN
Access Type
Author Information
Download PDF
Subscribe to digest